AstraZeneca: all 4,196 studies
Page 5 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- A Study of AZD8233 in Participants With Dyslipidemia.CompletedNCT04823611Phase 1/2Results posted
- Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy SubjectsCompletedNCT04788641Phase 1Results posted
- Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung CancerCompletedNCT04774380Phase 3Results posted
- A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)Active, not recruitingNCT04765059Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré SyndromeCompletedNCT04752566Phase 3Results posted
- Study of AZD2811 + Durvalumab in ES-SCLCActive, not recruitingNCT04745689Phase 2Results posted
- Ravulizumab in Thrombotic Microangiopathy Associated With a TriggerTerminatedNCT04743804Phase 3Results posted
- A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast CancerActive, not recruitingNCT04739761Phase 3Results posted
- A Study of ALXN1830 in Healthy Adult ParticipantsTerminatedNCT04730804Phase 1Results posted
- Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney DiseaseTerminatedNCT04727528Phase 3Results posted
- Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)CompletedNCT04724837Phase 2Results posted
- Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient AdultsCompletedNCT04723394Phase 3Results posted
- Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT04712903Phase 3Results posted
- Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving SpironolactoneCompletedNCT04676646Phase 4Results posted
- A Study of the Efficacy and Safety of MEDI7352 in Participants With Painful Osteoarthritis of the KneeCompletedNCT04675034Phase 2Results posted
- Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With AsthmaCompletedNCT04673630Phase 1Results posted
- A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)CompletedNCT04655027Phase 4Results posted
- Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled CorticosteroidsTerminatedNCT04643158Phase 2Results posted
- Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.CompletedNCT04642469Phase 3Results posted
- A Study of AZD8233 in Participants With DyslipidemiaCompletedNCT04641299Phase 2Results posted
- A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating MutationsActive, not recruitingNCT04639219Phase 2Results posted
- Study of ALXN1820 in Healthy Adult ParticipantsCompletedNCT04631562Phase 1Results posted
- A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic BronchitisCompletedNCT04631016Phase 2Results posted
- AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood CancerCompletedNCT04630756Phase 1/2Results posted
- Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in AdultsCompletedNCT04625972Phase 3Results posted
- Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.CompletedNCT04625725Phase 3Results posted
- A Phase 3 Study of ALXN2060 in Japanese Participants With Symptomatic ATTR-CMCompletedNCT04622046Phase 3Results posted
- A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.TerminatedNCT04612790Phase 3Results posted
- A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO)TerminatedNCT04612725Phase 2Results posted
- Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial InfarctionCompletedNCT04610892Phase 2Results posted
- Bioavailability Study of 2 Oral Formulations of ALXN1840CompletedNCT04610580Phase 1Results posted
- Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)CompletedNCT04609904Phase 3Results posted
- Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)CompletedNCT04609878Phase 3Results posted
- A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLCActive, not recruitingNCT04606771Phase 2Results posted
- A Study of CIN-107 in Adults With Primary AldosteronismCompletedNCT04605549Phase 2Results posted
- Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic DermatitisTerminatedNCT04605094Phase 2Results posted
- A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and FormoterolCompletedNCT04600505Phase 1Results posted
- Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney DiseaseCompletedNCT04595370Phase 2Results posted
- Copper Balance in Healthy Participants Administered ALXN1840CompletedNCT04594252Phase 1Results posted
- Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck CancerActive, not recruitingNCT04590963Phase 3Results posted
- A Study of Adavosertib as Treatment for Uterine Serous CarcinomaCompletedNCT04590248Phase 2Results posted
- A Study to Investigate the Biological Effects of AZD9833 in Women With ER-positive, HER2 Negative Primary Breast CancerCompletedNCT04588298Phase 2Results posted
- Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic AcidemiaTerminatedNCT04581785Phase 1/2Results posted
- Copper and Molybdenum Balance in Participants With Wilson Disease Treated With ALXN1840CompletedNCT04573309Phase 2Results posted
- Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe AsthmaCompletedNCT04570657Phase 2Results posted
- Study of AZD1222 for the Prevention of COVID-19 in JapanCompletedNCT04568031Phase 1/2Results posted
- Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.CompletedNCT04564742Phase 3Results posted
- Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)TerminatedNCT04564339Phase 2Results posted
- A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced CancerCompletedNCT04564027Phase 2Results posted
- A Study of the Cardiac Effects of ALXN1840 in Healthy AdultsCompletedNCT04560816Phase 1Results posted
- Study of Ravulizumab in Pediatric Participants With HSCT-TMACompletedNCT04557735Phase 3Results posted
- Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 DiabetesCompletedNCT04556760Phase 2Results posted
- A Study in Healthy Subjects to Assess Drug Availability of 4 Different Formulations of Verinurad and AllopurinolCompletedNCT04550234Phase 1Results posted
- Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell TransplantCompletedNCT04543591Phase 3Results posted
- A Study of Benralizumab in Patients With Eosinophilic EsophagitisTerminatedNCT04543409Phase 3Results posted
- Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy VolunteersCompletedNCT04532918Phase 1Results posted
- Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy ParticipantsCompletedNCT04526210Phase 1Results posted
- Phase 1 Study of ALXN1840 on the Metabolism of a CYP2C9 Substrate in Healthy Participants.CompletedNCT04526197Phase 1Results posted
- A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)CompletedNCT04519658Phase 2Results posted
- Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in AdultsCompletedNCT04516746Phase 3Results posted
- A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes MellitusCompletedNCT04515849Phase 2Results posted
- A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)Active, not recruitingNCT04512235Phase 3Results posted
- AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19CompletedNCT04507256Phase 1Results posted
- A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)Active, not recruitingNCT04504825Phase 3Results posted
- Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19TerminatedNCT04497948Phase 1Results posted
- A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.CompletedNCT04495179Phase 2Results posted
- Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast CancerActive, not recruitingNCT04494425Phase 3Results posted
- Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN DeficiencyActive, not recruitingNCT04493853Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney DiseaseTerminatedNCT04492722Phase 2Results posted
- Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised ChildrenCompletedNCT04484935Phase 2Results posted
- Danicopan as Add-on Therapy to a C5 Inhibitor in Paroxysmal Nocturnal Hemoglobinuria (PNH) Participants Who Have Clinically Evident Extravascular Hemolysis (EVH)(ALPHA)CompletedNCT04469465Phase 3Results posted
- Durvalumab Plus Chemotherapy in ES-SCLC (Oriental)CompletedNCT04449861Phase 3Results posted
- To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus PatientsCompletedNCT04445714Phase 4Results posted
- Copper Concentration & Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840CompletedNCT04422431Phase 2Results posted
- Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLCCompletedNCT04416633Phase 4Results posted
- Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)CompletedNCT04385368Phase 3Results posted
- Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.TerminatedNCT04381494Phase 4Results posted
- Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.CompletedNCT04380688Phase 2Results posted
- Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe PneumoniaTerminatedNCT04369469Phase 3Results posted
- A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung CancerActive, not recruitingNCT04351555Phase 3Results posted
- Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.CompletedNCT04346199Phase 2Results posted
- Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast CancerCompletedNCT04330040Phase 4Results posted
- Study of Verinurad in Heart Failure With Preserved Ejection FractionCompletedNCT04327024Phase 2Results posted
- Ravulizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Currently Treated With High-Dose EculizumabCompletedNCT04320602Phase 4Results posted
- Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast CancerActive, not recruitingNCT04305496Phase 3Results posted
- PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic AsthmaCompletedNCT04305405Phase 3Results posted
- A Study to Evaluate the Safety and Tolerability of CAEL-101 in Patients With AL AmyloidosisCompletedNCT04304144Phase 2Results posted
- Open-label Extension Study of Brazikumab in Ulcerative ColitisTerminatedNCT04277546Phase 2Results posted
- Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial CancerActive, not recruitingNCT04269200Phase 3Results posted
- A Study to Assess the Effect of Verinurad on the Electric Activity of the HeartCompletedNCT04256629Phase 1Results posted
- Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for ChemotherapyCompletedNCT04249362Phase 2Results posted
- An Efficacy and Safety Study of Ravulizumab in ALS ParticipantsTerminatedNCT04248465Phase 3Results posted
- Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent SurgeryTerminatedNCT04233073Phase 2Results posted
- Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese SubjectsCompletedNCT04217590Phase 3Results posted
- A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast CancerActive, not recruitingNCT04214288Phase 2Results posted
- Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic DermatitisCompletedNCT04212169Phase 2Results posted
- An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSDCompletedNCT04201262Phase 3Results posted
- A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)Active, not recruitingNCT04191304Phase 3Results posted
- A Phase 2b Diabetic Kidney Disease StudyCompletedNCT04170543Phase 2Results posted
- Study of the Oral Factor D (FD) Inhibitor ALXN2050 in PNH Patients as MonotherapyTerminatedNCT04170023Phase 2Results posted